Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee: Complete Statistical AnalysisIndependent statistical analysis of Study of FX006 vs Normal Saline in Patients With Osteoarthritis of the Knee: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Gardasil in Mid-Adult Males (MAM): Complete Statistical AnalysisIndependent statistical analysis of Study of Gardasil in Mid-Adult Males (MAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01432574).
- Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs): Complete Statistical AnalysisIndependent statistical analysis of Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Glycopyrronium in Axillary Hyperhydrosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Glycopyrronium in Axillary Hyperhydrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02530281).
- Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair: Complete Statistical AnalysisIndependent statistical analysis of Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048): Complete Statistical AnalysisIndependent statistical analysis of Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) + Ribavirin in Participants With Chronic Hepatitis C Who Failed Prior Direct-Acting Antiviral Therapy (MK-5172-048): primary endpoint results, effect estimate with…
- Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK1278863 to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00460655).
- Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00460564).
- Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of GSK2586881 on Acute Hypoxia and Exercise: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK2586881 on Acute Hypoxia and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03000686).
- Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK2862277 in Subjects Undergoing Oesophagectomy Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02221037).
- Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate…
- Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: Complete Statistical AnalysisIndependent statistical analysis of Study of GSK3965193 in Healthy Participants and Participants Living With Chronic Hepatitis B Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD: Complete Statistical AnalysisIndependent statistical analysis of Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib: Complete Statistical AnalysisIndependent statistical analysis of Study of High Dose Carfilzomib in Multiple Myeloma Patients Who Have Progressed On Standard Dose Carfilzomib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of High-Dose Rituximab With Temozolomide as Treatment for Primary Central Nervous System (CNS) Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate: Complete Statistical AnalysisIndependent statistical analysis of Study of How the Dose of Dialysis is Affected by Dialysate Flow Rate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA): Complete Statistical AnalysisIndependent statistical analysis of Study of Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis (JIA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate: Complete Statistical AnalysisIndependent statistical analysis of Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01950520).
- Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00831623).
- Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Study of Hypofractionated Radiotherapy Alone in Locally Advanced Nonsmall Cell Lung Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment: Complete Statistical AnalysisIndependent statistical analysis of Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom’s Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing: Complete Statistical AnalysisIndependent statistical analysis of Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing: primary endpoint results, effect estimate with confidence…
- Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD: Complete Statistical AnalysisIndependent statistical analysis of Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma: Complete Statistical AnalysisIndependent statistical analysis of Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma: primary endpoint results, effect estimate with…
- Study of IMC-11F8 in Participants With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of IMC-11F8 in Participants With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01088464).
- Study of IMC-11F8 in Participants With Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of IMC-11F8 in Participants With Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00835185).
- Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy: Complete Statistical AnalysisIndependent statistical analysis of Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in…
- Study of Impact of Behavioral Intervention- Exercise, Nutrition, Education- on Body Mass Index (BMI): Complete Statistical AnalysisIndependent statistical analysis of Study of Impact of Behavioral Intervention- Exercise, Nutrition, Education- on Body Mass Index (BMI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Study of INCB086550 in Select Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Study of INCB086550 in Select Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04629339).
- Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM: Complete Statistical AnalysisIndependent statistical analysis of Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01214187).
- Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices: Complete Statistical AnalysisIndependent statistical analysis of Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler Devices: primary endpoint results, effect estimate with confidence…
- Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC): Complete Statistical AnalysisIndependent statistical analysis of Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib: Complete Statistical AnalysisIndependent statistical analysis of Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04327700).
- Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures: Complete Statistical AnalysisIndependent statistical analysis of Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00594945).